Scholarlink

<p>Donor funding has remained central to Nigeria’s HIV response over the past two decades, supporting the expansion of prevention, treatment, and health system services while raising concerns about sustainability and dependence on external financing. This scoping review maps and synthesizes evidence on the roles, impacts, and challenges of donor-funded HIV interventions in Nigeria using the Arksey and O’Malley framework and the Joanna Briggs Institute guidance. Searches were conducted in PubMed, Scopus, Embase, Web of Science, and African Journals Online for peer-reviewed studies, policy documents, and program evaluations published between 2015 and 2025. Seven studies met the inclusion criteria. PEPFAR and the Global Fund were identified as the major donors, supporting HIV programs through direct service delivery, technical assistance, and performance-based financing. Donor-supported interventions improved antiretroviral therapy coverage, HIV testing uptake, viral load monitoring, and retention in care, particularly in high-burden states such as Rivers, Akwa Ibom, and Cross River. Investments also strengthened laboratory infrastructure, supply chains, workforce training, and health information systems. However, the evidence highlighted persistent challenges, including program verticalization, workforce imbalances linked to donor-funded salary disparities, fragmented service delivery, and continued reliance on external financing, which accounts for over 70% of Nigeria’s HIV expenditure. Key populations continue to face barriers related to stigma, discrimination, criminalization, and inadequate targeted funding. While donor funding has significantly improved HIV service coverage and health system capacity in Nigeria, long-term progress will depend on stronger domestic financing, integrated service delivery, improved governance, and rights-based approaches that address persistent inequities in access to care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A scoping review of the role of donor funding in HIV interventions in Nigeria

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月4日

查看全文
  • Taiwo Oluwaseun Sokunbi,
  • Abbas Bashir Umar,
  • Don-Pedro Ume,
  • Uko Bassey Eyo,
  • Mohammed Bello,
  • Abdul-roqeeb Temiloluwa Solotan,
  • Elijah Orimisan Akinbi,
  • Victor Ayotunde Osundele

摘要

Donor funding has remained central to Nigeria’s HIV response over the past two decades, supporting the expansion of prevention, treatment, and health system services while raising concerns about sustainability and dependence on external financing. This scoping review maps and synthesizes evidence on the roles, impacts, and challenges of donor-funded HIV interventions in Nigeria using the Arksey and O’Malley framework and the Joanna Briggs Institute guidance. Searches were conducted in PubMed, Scopus, Embase, Web of Science, and African Journals Online for peer-reviewed studies, policy documents, and program evaluations published between 2015 and 2025. Seven studies met the inclusion criteria. PEPFAR and the Global Fund were identified as the major donors, supporting HIV programs through direct service delivery, technical assistance, and performance-based financing. Donor-supported interventions improved antiretroviral therapy coverage, HIV testing uptake, viral load monitoring, and retention in care, particularly in high-burden states such as Rivers, Akwa Ibom, and Cross River. Investments also strengthened laboratory infrastructure, supply chains, workforce training, and health information systems. However, the evidence highlighted persistent challenges, including program verticalization, workforce imbalances linked to donor-funded salary disparities, fragmented service delivery, and continued reliance on external financing, which accounts for over 70% of Nigeria’s HIV expenditure. Key populations continue to face barriers related to stigma, discrimination, criminalization, and inadequate targeted funding. While donor funding has significantly improved HIV service coverage and health system capacity in Nigeria, long-term progress will depend on stronger domestic financing, integrated service delivery, improved governance, and rights-based approaches that address persistent inequities in access to care.